Debbie Coulson’s story
Debbie (Debs) Coulson, 58, from Colchester was diagnosed with glioblastoma in 2017.
Understanding the condition and connecting with others with the illness can help you feel empowered on your GBM journey.
GBM is one of the most aggressive cancers and one of the hardest to treat, and as a result survival rates are low, with just a 5% five-year survival rate. Existing treatments are not a cure, but a way to extend life. The current standard of care is unlikely to remove the entire tumor. It might no longer be visible following treatment, yet tiny pieces can remain and for the majority of people the tumor returns. On your GBM journey you should equip yourself with as much knowledge as possible to ensure you are aware of the options available beyond standard treatments.
Debbie (Debs) Coulson, 58, from Colchester was diagnosed with glioblastoma in 2017.
Alex Bennett-Clemmow was a carer for her mother Jana Bennett, who was diagnosed with GBM in 2019.
Kyle Humphries, who lives in New York City, is a GBM survivor who has been through surgery, a clinical trial and integrative medicines.
Yaron was working as a genomics researcher, tasked with sequencing the SARS genome in April 2003.
Liaquat, Maryam’s father, was diagnosed with GBM in November 2020 and died six months after diagnosis.
Debbie (Debs) Coulson, 58, from Colchester was diagnosed with glioblastoma in 2017.
Alex Bennett-Clemmow was a carer for her mother Jana Bennett, who was diagnosed with GBM in 2019.
Kyle Humphries, who lives in New York City, is a GBM survivor who has been through surgery, a clinical trial and integrative medicines.
Yaron was working as a genomics researcher, tasked with sequencing the SARS genome in April 2003.
Liaquat, Maryam’s father, was diagnosed with GBM in November 2020 and died six months after diagnosis.